Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer

NCT03622385 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT03622385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03622385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
Lead sponsor
Baylor Research Institute
Phase
Observational
Overall status
Completed
Start date
February 19, 2019
Completion date
September 28, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer